[1] Aronson J, Johnson E, Harp JH. Local bone transportation for treatment of intercalary defects by the Ilizarov technique. Biomechanical and clinical considerations [J]. Clin Orthop Relat Res, 1989, 243∶71-79 [2] Garcia-Montoya IA, Cendon TS, Arevalo-Gallegos S, Rascon-Cruz Q. Lactoferrin a multiple bioactive protein: an overview [J]. Biochim Biophys Acta,2012,1820∶226-236 [3] Naot D, Grey A, Reid IR, Cornish J. Lactoferrin--a novel bone growth factor [J]. Clin Med Res, 2005, 3∶93-101 [4] Guo HY, Jiang L, Ibrahim SA, et al. Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats [J]. J Nutr, 2009, 139∶958-964 [5] Naot D, Grey A, Reid IR, et al. Lactoferrin--a novel bone growth factor [J]. Clin Med Res, 2005, 3∶93-101 [6] Blais A, Malet A, Mikogami T, et al. Oral bovine lactoferrin improves bone status of ovariectomized mice [J]. Am J Physiol Endocrinol Metab, 2009, 296∶E1281-1288 [7] Grey A, Zhu Q, Watson M, et al. Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway [J]. Mol Cell Endocrinol, 2006, 251∶96-102 [8] Grey A, Banovic T, Zhu Q, et al. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells [J]. Mol Endocrinol, 2004, 18∶2268-2278 [9] Naot D, Chhana A, Matthews BG, et al. Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts [J]. Bone, 2011, 49∶217-224 [10] Cornish J, Naot D. Lactoferrin as an effector molecule in the skeleton [J]. Biometals, 2010, 23∶425-430 |